BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17092632)

  • 1. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
    Taccoen X; Valeri A; Descotes JL; Morin V; Stindel E; Doucet L; Joulin V; Bocqueraz F; Coulange C; Rambeaud JJ; Fournier G; Mejean A;
    Eur Urol; 2007 Apr; 51(4):980-7. PubMed ID: 17092632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
    Verhoest G; Veillard D; Guillé F; De La Taille A; Salomon L; Abbou CC; Valéri A; Lechevallier E; Descotes JL; Lang H; Jacqmin D; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Mejean A; Patard JJ
    Eur Urol; 2007 May; 51(5):1298-304; discussion 1304-5. PubMed ID: 17174023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.
    Thoroddsen A; Einarsson GV; Hardarson S; Petursdottir V; Magnusson J; Jonsson E; Gudbjartsson T
    Scand J Urol Nephrol; 2008; 42(2):121-5. PubMed ID: 18365922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.
    Rodríguez A; Patard JJ; Lobel B
    Arch Esp Urol; 2002 Oct; 55(8):969-75. PubMed ID: 12455292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival.
    Jeong IG; Yoo CH; Song K; Park J; Cho YM; Song C; Hong JH; Ahn H; Kim CS
    J Urol; 2009 Aug; 182(2):445-50. PubMed ID: 19524959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.
    Gudbjartsson T; Thoroddsen A; Petursdottir V; Hardarson S; Magnusson J; Einarsson GV
    Urology; 2005 Dec; 66(6):1186-91. PubMed ID: 16360438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
    Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
    J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
    Jeong IG; Jeong CW; Hong SK; Kwak C; Lee E; Lee SE
    Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
    Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.